August 21, 2011
Today, Dr. Parkash Gill announced that Veglin is again being released for continued Phase 2 Clinical Trials by FDA approval. According to Gill, the studies for Veglin should be open within the month. He has completed and turned in the protocol and detail as required which will allow Phase 2 clinical studies to soon start up again on Veglin. Also, a Phase 1 clinical study on Eph B4, Dr. Gills other molecule, should be available soon.
Ask Dr. Gill about the upcoming study of Veglin, Phase 2 clinical trials… Click Here
Learn about Veglin at this MesoRFA link: read more…
And learn about participating in a clinical trial at these MesoRFA links: